European Paediatric Formulation Initiative workshop report: Improving the administration of oral liquid medicines in paediatrics using dosing syringes and enteral accessories.
Administration oral
Dosing accuracy
Drug development
EMA
Infant
Medical device
Medication error
Medication safety
Newborn
Paediatric
Journal
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
ISSN: 1873-3441
Titre abrégé: Eur J Pharm Biopharm
Pays: Netherlands
ID NLM: 9109778
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
30
09
2019
revised:
03
04
2020
accepted:
09
04
2020
pubmed:
15
4
2020
medline:
10
2
2021
entrez:
15
4
2020
Statut:
ppublish
Résumé
Accurate dosing of the right medicine to the right patient is a key element of safe and efficacious pharmacotherapy, yet prone to technical challenges and human error when dosing involves the administration of small volumes of liquid medicines. For this reason, the topic has gained increased attention over the last decade from multiple stakeholder parties e.g. academia, hospital pharmacy, the medical device and pharmaceutical industry, and regulatory agencies. It is now well acknowledged that spoons and cups are not suitable for the measurement of small volumes of oral liquid medicines and that syringes are a better alternative, but syringes for parenteral use should not be used for oral dosing in order to avoid accidental parenteral delivery of oral products. However, dosing accuracy of very small volumes of liquid medicines to young children, and especially pre-term neonates, is still not sufficiently ensured. A workshop was organised in 2018 by the European Paediatric Formulation Initiative to reflect on current status and challenges (first part) and possible strategies to improve the present situation (second part). A voting system (n = 24) was used to consider the most favourable solutions. The harmonisation and/or standardisation of the technical design of oral syringes (including e.g. female/male connection) was considered a key priority.
Identifiants
pubmed: 32289491
pii: S0939-6411(20)30100-4
doi: 10.1016/j.ejpb.2020.04.007
pii:
doi:
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
91-97Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest Rutger de Vries & Diana van Riet-Nales are members of the European Medicines Agency (EMA) Paediatric Committee (PDCO) Formulation Working Group (FWG). Diana van Riet-Nales is also member of the EMA Quality Working Party and the Dutch Medicines Evaluation Board (MEB) Committee on Clinical Practice. Diana van Riet-Nales was rapporteur for the EMA Guideline on pharmaceutical development of medicines for paediatric use, the reflection paper on the pharmaceutical development of medicines for use in the older population and the EMA Q&A on small volumes. She was a drafting group member of the Q&A on enteral feeding and the EMA guideline on drug device combination products. Rutger de Vries supported the work on the paediatric guideline. He was a member of the drafting group on the EMA Q&A for small volumes and enteral feeding. Jennifer Walsh, Esmerald Hermans, Gareth Hilton, Paul Blowers and Smita Salunke are members of the European Paediatric Formulation Initiative. This Workshop did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. None of the authors or speakers received any compensation or funding for the Workshop or manuscript publication.